O
MACK

OrbiMed’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

OrbiMed’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-73,600
Closed -$843K – 132
2022
Q4 		$843K Buy
+73,600
New +$843K 0.02% 111